Key Highlights

  • Aveanna Healthcare Holdings (NASDAQ:AVAH) is up 86.06% over six months and 27.92% over three months, per published market data on October 7, 2026, with a market cap near USD 2.68 billion.
  • Second quarter Revenue rose 13.7% to USD 670.5 million and Net Income reached USD 40.3 million, up from USD 27.0 million a year earlier, according to the company release of August 13, 2026.
  • Management raised 2026 guidance to revenue above USD 2.68 billion from USD 2.63 billion to USD 2.65 billion, and adjusted EBITDA above USD 365 million from USD 338 million to USD 342 million.
  • At USD 12.28 the stock carries a published P/E of 10.0, yet total indebtedness of USD 1,483.4 million and heavy Medicaid reliance keep the risk profile elevated.

What Aveanna Reported on August 13, 2026

Aveanna Healthcare Holdings announced second quarter results and revised 2026 guidance on August 13, 2026. Revenue of USD 670.5 million was up 13.7% from USD 589.6 million a year earlier. Net income was USD 40.3 million versus USD 27.0 million, and adjusted EBITDA grew 8.0% to USD 95.4 million. The company lifted full year revenue guidance to above USD 2.68 billion and adjusted EBITDA guidance to above USD 365 million. Growth came from all three segments. Private duty services revenue rose USD 67.9 million, home health and hospice added USD 8.9 million, and medical solutions added USD 4.1 million. Operating Cash Flow for the six months was USD 85.3 million, with free cash flow of USD 75.4 million.

Why Private Duty Services Drive the Story

Aveanna delivers in-home nursing and care, mostly to medically complex children, and the bulk of its payers are state Medicaid programs. Revenue rises when it can staff more hours of care and when states pay better rates, so the private duty segment, which supplied most of the quarter's growth, is the engine. Because nurse wages are the main cost, higher reimbursement flows to profit quickly, which helps explain why guidance for adjusted EBITDA was raised by more than revenue. Published market data on October 7, 2026 shows a price of USD 12.28, a P/E of 10.0 and a market cap of about USD 2.68 billion. Simple arithmetic on two published numbers puts the new EBITDA floor at over 13.6% of the revenue floor.

Risks and What to Watch

Debt is the central risk. As of July 4, 2026 the company reported total indebtedness of USD 1,483.4 million against cash of USD 97.2 million and USD 225.5 million of available revolver capacity, so interest costs absorb a large share of operating profit. Medicaid funding is also a policy variable, since state budgets and federal changes can alter rates and eligibility. Wage Inflation and nurse availability could cap Volume growth. The stock rose 0.49% on October 7, 2026, and it has already moved sharply, so expectations are higher. The third quarter report is the next catalyst, though no confirmed date appears in the verified material.

Where Things Stand

Aveanna Healthcare (NASDAQ:AVAH) is up 86.1% in six months because it beat on the second quarter, grew revenue 13.7% and raised both revenue and adjusted EBITDA guidance. A published P/E of 10.0 looks low for that growth, but the Debt load and Medicaid dependence explain part of the discount. Investors should watch rates, Leverage and the next report. This article is informational and is not Investment advice.